Home

Earlier today, the MAPRx Coalition and 27 of its member organizations submitted letters to House and Senate leadership in response to the ongoing congressional efforts to address drug pricing and affordability.

Specifically, the letters urged congressional leaders to focus on the following policies to improve the beneficiary experience... Read more

Earlier today, the MAPRx Coalition and 38 health advocacy organizations sent a letter to Health and Human Services (HHS) Secretary Designee Xavier Becerra in opposition to recent proposed changes to Medicare Part D, including the longstanding six protected classes policy.

The changes, announced on January 19 in the final days of the previous... Read more

The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2020 – December 7, 2020 for coverage beginning January 1, 2021. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole may also impact how beneficiaries move through... Read more

Earlier today, the MAPRx Coalition and 28 of its members, representing national patient, caregiver, and healthcare provider organizations, submitted comments to the Centers for Medicare and Medicaid Services (CMS) on their latest rule. Over the past 15 years, the Medicare Part D program has provided a critical avenue for beneficiaries to access prescription drugs. Its success in providing millions of Medicare beneficiaries with... Read more

Earlier today, the Medicare Access for Patients Rx Coalition (MAPRx) provided the Centers for Medicare & Medicaid Services (CMS) with our official commentary in response to the Advance Notice of Methodological Changes for Calendar Year 2021 for Medicare Advantage Capitation Rates and Part C and Part D Payment Policies – Part II released on February 5, 2020. Click here to... Read more

Earlier today, the Medicare Access for Patients Rx (MAPRx) Coalition submitted a letter, signed by 33 member organizations, to Senators Bill Cassidy and Bob Menendez in support of their legislation to address out-of-pocket (OOP) costs for Medicare Part D beneficiaries. S. 2911, the Seniors Prescription Drug Relief Act of 2019, includes a much-needed smoothing mechanism that would allow Medicare beneficiaries to spread... Read more